Logo image of LPSN

LIVEPERSON INC (LPSN) Stock Fundamental Analysis

NASDAQ:LPSN - Nasdaq - US5381461012 - Common Stock - Currency: USD

0.8874  +0.03 (+3.38%)

After market: 0.89 +0 (+0.29%)

Fundamental Rating

1

Overall LPSN gets a fundamental rating of 1 out of 10. We evaluated LPSN against 281 industry peers in the Software industry. Both the profitability and financial health of LPSN have multiple concerns. LPSN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

LPSN had negative earnings in the past year.
In the past year LPSN has reported a negative cash flow from operations.
In the past 5 years LPSN always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: LPSN reported negative operating cash flow in multiple years.
LPSN Yearly Net Income VS EBIT VS OCF VS FCFLPSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M

1.2 Ratios

With a Return On Assets value of -22.09%, LPSN is not doing good in the industry: 69.04% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -22.09%
ROE N/A
ROIC N/A
ROA(3y)-18.28%
ROA(5y)-15.21%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LPSN Yearly ROA, ROE, ROICLPSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300

1.3 Margins

Looking at the Gross Margin, with a value of 70.11%, LPSN is in line with its industry, outperforming 55.87% of the companies in the same industry.
LPSN's Gross Margin has been stable in the last couple of years.
LPSN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 70.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.73%
GM growth 5Y-0.79%
LPSN Yearly Profit, Operating, Gross MarginsLPSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

1

2. Health

2.1 Basic Checks

LPSN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LPSN has more shares outstanding
The number of shares outstanding for LPSN has been increased compared to 5 years ago.
LPSN has a worse debt/assets ratio than last year.
LPSN Yearly Shares OutstandingLPSN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
LPSN Yearly Total Debt VS Total AssetsLPSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -1.87, we must say that LPSN is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -1.87, LPSN is not doing good in the industry: 76.51% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.87
ROIC/WACCN/A
WACC2.48%
LPSN Yearly LT Debt VS Equity VS FCFLPSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.65 indicates that LPSN should not have too much problems paying its short term obligations.
LPSN has a Current ratio of 1.65. This is comparable to the rest of the industry: LPSN outperforms 50.18% of its industry peers.
A Quick Ratio of 1.65 indicates that LPSN should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.65, LPSN perfoms like the industry average, outperforming 50.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.65
LPSN Yearly Current Assets VS Current LiabilitesLPSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for LPSN have decreased strongly by -22.05% in the last year.
The Revenue for LPSN has decreased by -22.26% in the past year. This is quite bad
LPSN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.39% yearly.
EPS 1Y (TTM)-22.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-164.58%
Revenue 1Y (TTM)-22.26%
Revenue growth 3Y-12.7%
Revenue growth 5Y1.39%
Sales Q2Q%-23.32%

3.2 Future

The Earnings Per Share is expected to grow by 16.41% on average over the next years. This is quite good.
LPSN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -9.27% yearly.
EPS Next Y38.8%
EPS Next 2Y16.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-19.58%
Revenue Next 2Y-9.27%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LPSN Yearly Revenue VS EstimatesLPSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
LPSN Yearly EPS VS EstimatesLPSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LPSN. In the last year negative earnings were reported.
Also next year LPSN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LPSN Price Earnings VS Forward Price EarningsLPSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LPSN Per share dataLPSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

LPSN's earnings are expected to grow with 16.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.41%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LPSN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIVEPERSON INC

NASDAQ:LPSN (5/2/2025, 8:00:00 PM)

After market: 0.89 +0 (+0.29%)

0.8874

+0.03 (+3.38%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-05 2025-03-05/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners24.58%
Inst Owner Change-0.19%
Ins Owners6.36%
Ins Owner Change-1.89%
Market Cap81.03M
Analysts50
Price Target0.97 (9.31%)
Short Float %15.82%
Short Ratio8.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-251.09%
Min EPS beat(2)-460.85%
Max EPS beat(2)-41.32%
EPS beat(4)1
Avg EPS beat(4)-48.99%
Min EPS beat(4)-460.85%
Max EPS beat(4)331.92%
EPS beat(8)3
Avg EPS beat(8)-39.31%
EPS beat(12)5
Avg EPS beat(12)-25.77%
EPS beat(16)9
Avg EPS beat(16)-4.7%
Revenue beat(2)2
Avg Revenue beat(2)3.82%
Min Revenue beat(2)2.33%
Max Revenue beat(2)5.3%
Revenue beat(4)4
Avg Revenue beat(4)3.08%
Min Revenue beat(4)1.22%
Max Revenue beat(4)5.3%
Revenue beat(8)5
Avg Revenue beat(8)1.16%
Revenue beat(12)7
Avg Revenue beat(12)0.39%
Revenue beat(16)9
Avg Revenue beat(16)0.43%
PT rev (1m)-1.3%
PT rev (3m)-1.3%
EPS NQ rev (1m)-70.18%
EPS NQ rev (3m)-25.43%
EPS NY rev (1m)-40.91%
EPS NY rev (3m)7.46%
Revenue NQ rev (1m)-0.77%
Revenue NQ rev (3m)-2.81%
Revenue NY rev (1m)-3.62%
Revenue NY rev (3m)-4.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.26
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.55
EYN/A
EPS(NY)-0.95
Fwd EYN/A
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS3.42
BVpS-0.74
TBVpS-3.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.09%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 70.11%
FCFM N/A
ROA(3y)-18.28%
ROA(5y)-15.21%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.73%
GM growth 5Y-0.79%
F-Score4
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 66.75%
Cap/Sales 9.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.65
Quick Ratio 1.65
Altman-Z -1.87
F-Score4
WACC2.48%
ROIC/WACCN/A
Cap/Depr(3y)73.49%
Cap/Depr(5y)106.31%
Cap/Sales(3y)9.03%
Cap/Sales(5y)9.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-164.58%
EPS Next Y38.8%
EPS Next 2Y16.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.26%
Revenue growth 3Y-12.7%
Revenue growth 5Y1.39%
Sales Q2Q%-23.32%
Revenue Next Year-19.58%
Revenue Next 2Y-9.27%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year75.89%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-55.12%
OCF growth 3YN/A
OCF growth 5YN/A